Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1133-1145
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1133
Figure 1
Figure 1 Changes in surgical approaches for treating nonfunctioning-pancreatic neuroendocrine tumors over time. MIS: Minimally invasive surgery.
Figure 2
Figure 2 Comparison of disease-free survival rates between open pancreatic resection and minimally invasive approaches for treating patients with nonfunctioning pancreatic neuroendocrine tumors. DFS: Disease-free survival; MIS: Minimally invasive surgery; NF-PNET: Nonfunctioning-pancreatic neuroendocrine tumors.